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Purpose: To report a case of endophthalmitis following 25-gauge transconjunctival sutureless 
vitrectomy.
Design: Observational case report.
Methods: An 87-year-old male who underwent sutureless 25-gauge vitrectomy developed uni-
lateral endophthalmitis. Vitreous culture revealed Staphylococcus coagulase-negative bacteria.  
He was subsequently treated with intravitreal antibiotics and oral prednisone.
Results: The endophthalmitis resolved with a best corrected visual acuity of 6/200 with the 
presence of an epiretinal membrane.
Conclusions: Possible contributing factors to endophthalmitis following sutureless vitrectomy 
include decreased vitreous irrigation/lavage, lack of a watertight wound, and/or vitreous wick-
ing, all of which may promote intraocular bacterial entrance.  A sutureless vitrectomy system 
may increase the risk of vitrectomy-associated endophthalmitis.
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We have seen much in the literature recently about the 25-gauge transconjunctival 
sutureless vitrectomy system (TSV), which is quickly replacing many 19-gauge vit-
rectomy procedures (Fugii et al 2002). The TSV system allows for smaller wounds, 
reduced operative times, and theoretically less post-operative inﬂ  ammation; however 
there may be adverse outcomes associated with decreased sclerotomy size. To our 
knowledge, there have been only a few reported cases of endophthalmitis following 
25-gauge TSV (Taylor and Aylward 2005; Taban et al 2006; Acar et al 2007; Kunimoto 
et al 2007; Valmaggia 2007).
We recently performed a 25-gauge vitrectomy on an 87-year-old male in order 
to remove persistent dense vitreous hemorrhage associated with cataract surgery. 
His periorbital skin, eyelids, and conjunctiva were prepped pre-operatively with 5% 
povidone-iodine solution, but no sub-conjunctival injection of antibiotics was given at 
the end of the surgery. The vitrectomy was without any intraoperative complications 
and the operative time was 27 minutes. The vitreous was thoroughly removed, leaving 
only a small amount of vitreous skirt. Approximately thirty hours later he developed 
severe eye pain and vision was reduced to hand motion in the operative eye. Marked 
cell and ﬂ  are with dense vitritis were present. Acute post-operative endophthalmitis 
was diagnosed and a vitreous tap was performed, followed by intravitreal injection 
of 1.0 mg vancomycin and 2.0 mg ceftazidime, as well as initiation of topical gati-
ﬂ  oxacin. The vitreous culture grew coagulase-negative Staphylococcus, sensitive to 
all of the above antibiotics. The inﬂ  ammation gradually improved with antibiotic and 
prednisone drops and eight months after injection his vision was 6/200 with a quiet 
eye and epiretinal membrane present.Clinical Ophthalmology 2008:2(4) 936
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Endophthalmitis is rare following 19- or 20-gauge 
vitrectomy with 0.07% incidence reported (Cohen et al 
1995). The reason endophthalmitis rates following traditional 
vitrectomy surgery are historically low when compared to 
cataract surgery is unknown. A contributing factor may be 
greater vitrectomy irrigation ﬂ  uid volumes, allowing dilu-
tion of potential pathogens. The smaller incision diameter 
of the TSV system (0.57 mm versus 0.9 mm in 19-gauge) 
results in infusion rates decreased by a calculated factor 
of 6.9 (Fugii et al 2002). Infusion ﬂ  uid volume reduction 
during 25-gauge vitrectomy surgery may increase risk for 
bacterial infection.
Endophthalmitis following TVS vitrectomy may result 
from sutureless scleral wounds, mimicking risks inherent with 
sutureless clear cornea cataract extraction. Endophthalmitis 
rates following clear cornea cataract surgery are substantially 
higher than those seen after limbal incision surgery (Taban 
et al 2005). Intraocular pathogens may result from relative 
post-operative hypotony creating negative pressure through 
a nonwatertight wound, thus allowing retrograde intraocular 
ﬂ  ow of bacteria. Sutureless vitrectomy with nonwatertight 
incisions often results in relative hypotony with resultant 
possible similar retrograde bacterial seeding.
Endophthalmitis following TVS vitrectomy surgery 
may also be the result of a “vitreous wick”. Vitreous adher-
ent to a 19- or 20-gauge sclerotomy site is excised prior to 
closure. TSV vitrectomy results in vitreous incarceration at 
the sclerotomy site. Early cataract surgery demonstrated that 
a “vitreous wick” allows entrance of bacteria with resultant 
endophthalmitis (Ruiz and Teeters 1970).
While 25-gauge vitrectomy is an exciting tool, its use 
has the potential to increase the rate of vitrectomy associated 
endophthalmitis. The smaller incisions and shorter surgical 
times seen increasingly in retinal surgery mimic the sweep-
ing evolution observed in cataract surgery. As in sutureless 
cataract surgery, 25-gauge sutureless vitrectomy may result 
in an increased rate of endophthalmitis as compared with 
vitrectomies involving sutured sclerotomies.
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